| Cat. No. |
Product |
Quantity/Size |
Price |
Data |
|
| CPC539C |
Human Anti-SARS-CoV-2 Spike-RBD Bebtelovimab (LY-CoV1404 / LY3853113) Neutralizing mAb |
1.0 mg |
Please Inquire |
 |
BUY
|
| CPC539A |
Human Anti-SARS-CoV-2 Spike-RBD Bebtelovimab (LY-CoV1404 / LY3853113) Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC539B |
Human Anti-SARS-CoV-2 Spike-RBD Bebtelovimab (LY-CoV1404 / LY3853113) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC541B |
Human Anti-SARS-CoV-2 Spike-RBD Neutralizing (S2E12) mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC541C |
Human Anti-SARS-CoV-2 Spike-RBD Neutralizing (S2E12) mAb |
1.0 mg |
Please Inquire |
|
BUY
|
| CPC541A |
Human Anti-SARS-CoV-2 Spike-RBD Neutralizing (S2E12) mAb |
50 µg |
Please Inquire |
|
BUY
|
| FHB65410A |
Humanized Anti-Human SLC34A2 / NaPi2b (SAA0766) mAb |
100 ug |
$330.00
|
|
BUY
|
| FHB65410B |
Humanized Anti-Human SLC34A2 / NaPi2b (SAA0766) mAb |
1.0 mg |
$1,562.00
|
|
BUY
|
| FHJ04020A |
Mouse Anti-Human CD276 (Mab 8H9) mAb |
100 ug |
$475.00
|
|
BUY
|
| FHJ04020B |
Mouse Anti-Human CD276 (Mab 8H9) mAb |
1.0 mg |
$1,562.00
|
|
BUY
|
| DVV11801A |
Research Grade Anti-HPV18 L1/Major capsid protein L1 (H18L1-A) mAb |
100 µg |
$475.00
|
|
BUY
|
| DVV11801B |
Research Grade Anti-HPV18 L1/Major capsid protein L1 (H18L1-A) mAb |
1.0 mg |
$1,715.00
|
|
BUY
|
| DHD06901B |
Research Grade Anti-Human CD122/IL2RB (Mik beta 1) |
1.0 mg |
$1,560.00
|
|
BUY
|
| DHD06901A |
Research Grade Anti-Human CD122/IL2RB (Mik beta 1) |
100 ug |
$430.00
|
|
BUY
|
| DHF68801A |
Research Grade Anti-Human CD156b/ADAM17 (MEDI3622) |
100 ug |
$475.00
|
|
BUY
|
| DHF68801B |
Research Grade Anti-Human CD156b/ADAM17 (MEDI3622) |
1.0 mg |
$1,715.00
|
|
BUY
|
| DHJ05001A |
Research Grade Anti-Human IL31 (BMS-981164) |
100 ug |
$475.00
|
|
BUY
|
| DHJ05001B |
Research Grade Anti-Human IL31 (BMS-981164) |
1.0 mg |
$1,715.00
|
|
BUY
|
| DHD29901A |
Research Grade Anti-Human ITGB6 (SGN-B6A) |
100 ug |
$475.00
|
|
BUY
|
| DHD29901B |
Research Grade Anti-Human ITGB6 (SGN-B6A) |
1.0 mg |
$1,715.00
|
|
BUY
|
| DHK13704B |
Research Grade Anti-Human SIGLEC15/CD33L3 (DS1501) mAb |
1.0 mg |
$1,520.00
|
|
BUY
|
| DHK13704A |
Research Grade Anti-Human SIGLEC15/CD33L3 (DS1501) mAb |
100 µg |
$420.00
|
|
BUY
|
| DHK23201A |
Research Grade Anti-Human TNFRSF25 (PTX-35) mAb |
100 µg |
$475.00
|
|
BUY
|
| DHK23201B |
Research Grade Anti-Human TNFRSF25 (PTX-35) mAb |
1.0 mg |
$1,715.00
|
|
BUY
|
| DVV00317A |
Research Grade Anti-SARS-CoV-2 Spike-RBD (S2H97) mAb |
100 µg |
$420.00
|
|
BUY
|
| DVV00317B |
Research Grade Anti-SARS-CoV-2 Spike-RBD (S2H97) mAb |
1.0 mg |
$1,520.00
|
|
BUY
|
| DVV00317X-BT |
Research Grade Anti-SARS-CoV-2 Spike-RBD (S2H97) mAb, Biotin labeled |
0.5 mg |
$1,485.00
|
|
BUY
|
| DVV00317B-BT |
Research Grade Anti-SARS-CoV-2 Spike-RBD (S2H97) mAb, Biotin labeled |
1.0 mg |
$2,310.00
|
|
BUY
|
| DHJ64002B |
Research Grade Azintuxizumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHJ64002A |
Research Grade Azintuxizumab |
100 ug |
$380.00
|
|
BUY
|
| DHD47901B |
Research Grade Bemarituzumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHD47901A |
Research Grade Bemarituzumab |
100 ug |
$380.00
|
|
BUY
|
| DHH02210A |
Research Grade Budigalimab |
100 ug |
$380.00
|
|
BUY
|
| DHH02210B |
Research Grade Budigalimab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHD17401A |
Research Grade Citatuzumab |
100 ug |
$380.00
|
|
BUY
|
| DHD17401B |
Research Grade Citatuzumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHC09603A |
Research Grade Disitamab |
100 ug |
$380.00
|
|
BUY
|
| DHC09603B |
Research Grade Disitamab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DFJ05001A |
Research Grade Dovanvetmab |
100 ug |
$420.00
|
|
BUY
|
| DFJ05001B |
Research Grade Dovanvetmab |
1.0 mg |
$1,520.00
|
|
BUY
|
| DHC09608B |
Research Grade Ertumaxomab |
1.0 mg |
$2,030.00
|
|
BUY
|
| DHC09608A |
Research Grade Ertumaxomab |
100 ug |
$560.00
|
|
BUY
|
| DVV00306A |
Research Grade Etesevimab |
100 ug |
$475.00
|
|
BUY
|
| DVV00306B |
Research Grade Etesevimab |
1.0 mg |
$1,715.00
|
|
BUY
|
| DHJ04002B |
Research Grade Omburtamab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHJ04002A |
Research Grade Omburtamab |
100 ug |
$380.00
|
|
BUY
|
| DHL04002B |
Research Grade Omburtamab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHH02216A |
Research Grade Pidilizumab |
100 ug |
$380.00
|
|
BUY
|
| DHH02216B |
Research Grade Pidilizumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHJ48301B |
Research Grade Ponsegromab |
1.0 mg |
$1,520.00
|
|
BUY
|
| DHJ48301A |
Research Grade Ponsegromab |
100 ug |
$420.00
|
|
BUY
|
| DHC09612B |
Research Grade Runimotamab |
1.0 mg |
$2,235.00
|
|
BUY
|
| DHC09612A |
Research Grade Runimotamab |
100 ug |
$615.00
|
|
BUY
|
| DHC34203A |
Research Grade Telisotuzumab |
100 ug |
$420.00
|
|
BUY
|
| DHC34203B |
Research Grade Telisotuzumab |
1.0 mg |
$1,520.00
|
|
BUY
|
| DHC34299B |
Research Grade Telisotuzumab vedotin (ADC) |
5.0 mg |
$6,325.00
|
|
BUY
|
| DHC34299A |
Research Grade Telisotuzumab vedotin (ADC) |
1.0 mg |
$2,915.00
|
|
BUY
|
| DHC09605B |
Research Grade Timigutuzumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHC09605A |
Research Grade Timigutuzumab |
100 ug |
$380.00
|
|
BUY
|
| DHA30101A |
Research Grade Vesencumab |
100 ug |
$380.00
|
|
BUY
|
| DHA30101B |
Research Grade Vesencumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHD52901B |
Research Grade Vofatamab |
1.0 mg |
$1,520.00
|
|
BUY
|
| DHD52901A |
Research Grade Vofatamab |
100 ug |
$420.00
|
|
BUY
|
| DHJ92101B |
Research Grade Vopratelimab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHJ92101A |
Research Grade Vopratelimab |
100 ug |
$380.00
|
|
BUY
|
| DHE16605A |
Research Grade Vulinacimab |
100 ug |
$380.00
|
|
BUY
|
| DHE16605B |
Research Grade Vulinacimab |
1.0 ug |
$1,380.00
|
|
BUY
|
| DHC09609A |
Research Grade Zenocutuzumab |
100 ug |
$560.00
|
|
BUY
|
| DHC09609B |
Research Grade Zenocutuzumab |
1.0 mg |
$2,030.00
|
|
BUY
|
